CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the reference to our firm under the caption “Experts” in this Amendment No. 2 to Registration Statement on Form S-3 of PharmaCyte Biotech, Inc. for the registration of common stock and to the incorporation by reference therein of our report dated July 31, 2023, relating to the consolidated financial statements, which appears in PharmaCyte Biotech Inc.’s Annual Report on Form 10-K for the year ended April 30, 2023, filed with the Securities and Exchange Commission.
|/s/ Armanino LLP|
September 11, 2023